We proposed a pilot randomized control trial to develop a SB-reduction intervention focused on breaking sedentary time with standing/walking in CAD patients (n=70). However, little is known about the feasibility and preliminary efficacy of a technology-based SB reduction program for T2D patients in a free-living setting. In addition, the use of a smart water bottle may be a promising strategy to naturally break sedentary time due to the impact of increased water intake on kitchen and restroom breaks. Wearable technology can prompt users to take breaks from Reducing SB time with frequent standing/walking breaks is safe and offers cardiometabolic benefits. There is a pressing need to develop novel strategies to reduce SB and improve daily activity. Patients with T2D are particularly prone to high levels of SB (10-12 hours/day) and have a greater risk for the negative consequences of SB due to their low activity levels. Sedentary behavior (SB) is a strong modifiable risk factor for developing type 2 diabetes (T2D). Reducing Sedentary Time in Patients with Type 2 Diabetes: A Pilot Randomized Control Trial These P&F awards are supported by the Vanderbilt Diabetes Research Center (NIH grant DK20593). Vanderbilt Diabetes Center Discovery Program GrantĬovers diabetes and/or obesity-related pilot studies that utilize high-throughput facility BioVU and/or the mass spectrometry research centers Vanderbilt Diabetes Research Center P&F GrantĬovers basic and/or clinic research related to diabetes, metabolism, and/or obesity VDRC will be offering Pilot and Feasibility (P&F) Awards for 2023 in the following areas:
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |